CN106674286B - 四苯基卟啉乙醚芳基钌化合物及制备方法和用途 - Google Patents
四苯基卟啉乙醚芳基钌化合物及制备方法和用途 Download PDFInfo
- Publication number
- CN106674286B CN106674286B CN201611045995.9A CN201611045995A CN106674286B CN 106674286 B CN106674286 B CN 106674286B CN 201611045995 A CN201611045995 A CN 201611045995A CN 106674286 B CN106674286 B CN 106674286B
- Authority
- CN
- China
- Prior art keywords
- tetraphenylporphyrin
- ruthenium compound
- aryl ruthenium
- formula
- ether
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 title claims abstract description 40
- -1 Tetraphenylporphyrin ether aryl ruthenium compound Chemical class 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000003814 drug Substances 0.000 claims abstract description 7
- 229940079593 drug Drugs 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 6
- 238000001556 precipitation Methods 0.000 claims description 6
- 229910052707 ruthenium Inorganic materials 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- YKFLAYDHMOASIY-UHFFFAOYSA-N γ-terpinene Chemical compound CC(C)C1=CCC(C)=CC1 YKFLAYDHMOASIY-UHFFFAOYSA-N 0.000 claims description 6
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 239000013078 crystal Substances 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- DMOSASZSCBAMJD-UHFFFAOYSA-N 5,10,15,20-tetraphenyl-21,23-dihydroporphyrin-2-ol Chemical compound Oc1cc2[nH]c1c(-c1ccccc1)c1ccc(n1)c(-c1ccccc1)c1ccc([nH]1)c(-c1ccccc1)c1ccc(n1)c2-c1ccccc1 DMOSASZSCBAMJD-UHFFFAOYSA-N 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- LHIJANUOQQMGNT-UHFFFAOYSA-N aminoethylethanolamine Chemical compound NCCNCCO LHIJANUOQQMGNT-UHFFFAOYSA-N 0.000 claims 1
- 150000004032 porphyrins Chemical class 0.000 abstract description 6
- 206010028980 Neoplasm Diseases 0.000 abstract description 5
- 201000011510 cancer Diseases 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- 239000002775 capsule Substances 0.000 abstract description 2
- 239000000839 emulsion Substances 0.000 abstract description 2
- 238000002347 injection Methods 0.000 abstract description 2
- 239000007924 injection Substances 0.000 abstract description 2
- 239000006187 pill Substances 0.000 abstract description 2
- 239000000375 suspending agent Substances 0.000 abstract description 2
- 239000003826 tablet Substances 0.000 abstract 1
- YNHJECZULSZAQK-UHFFFAOYSA-N tetraphenylporphyrin Chemical compound C1=CC(C(=C2C=CC(N2)=C(C=2C=CC=CC=2)C=2C=CC(N=2)=C(C=2C=CC=CC=2)C2=CC=C3N2)C=2C=CC=CC=2)=NC1=C3C1=CC=CC=C1 YNHJECZULSZAQK-UHFFFAOYSA-N 0.000 description 12
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 5
- 230000000259 anti-tumor effect Effects 0.000 description 5
- 239000000460 chlorine Substances 0.000 description 5
- 229910052801 chlorine Inorganic materials 0.000 description 5
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 5
- YAYGSLOSTXKUBW-UHFFFAOYSA-N ruthenium(2+) Chemical compound [Ru+2] YAYGSLOSTXKUBW-UHFFFAOYSA-N 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 4
- 229910052697 platinum Inorganic materials 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- WWRCMNKATXZARA-UHFFFAOYSA-N 1-Isopropyl-2-methylbenzene Chemical compound CC(C)C1=CC=CC=C1C WWRCMNKATXZARA-UHFFFAOYSA-N 0.000 description 2
- 206010034133 Pathogen resistance Diseases 0.000 description 2
- 206010034972 Photosensitivity reaction Diseases 0.000 description 2
- 239000012327 Ruthenium complex Substances 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229960004756 ethanol Drugs 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 2
- 208000007578 phototoxic dermatitis Diseases 0.000 description 2
- 231100000018 phototoxicity Toxicity 0.000 description 2
- 150000003222 pyridines Chemical class 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000002895 emetic Substances 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0046—Ruthenium compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611045995.9A CN106674286B (zh) | 2016-11-22 | 2016-11-22 | 四苯基卟啉乙醚芳基钌化合物及制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611045995.9A CN106674286B (zh) | 2016-11-22 | 2016-11-22 | 四苯基卟啉乙醚芳基钌化合物及制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106674286A CN106674286A (zh) | 2017-05-17 |
CN106674286B true CN106674286B (zh) | 2019-01-29 |
Family
ID=58866581
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611045995.9A Active CN106674286B (zh) | 2016-11-22 | 2016-11-22 | 四苯基卟啉乙醚芳基钌化合物及制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106674286B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102015743A (zh) * | 2008-02-08 | 2011-04-13 | 本尤明·A·科恩 | 钌化合物和组合物 |
CN103239718A (zh) * | 2013-05-13 | 2013-08-14 | 江苏大学 | 负载阿霉素的聚己内酯-嵌段-聚乙二醇纳米微球的制备方法 |
CN103298804A (zh) * | 2009-04-29 | 2013-09-11 | 多异亚德韩国株式会社 | 新的二氢卟酚e6-叶酸共轭物、其制备方法以及含有该共轭物的用于癌症治疗的药物组合物 |
-
2016
- 2016-11-22 CN CN201611045995.9A patent/CN106674286B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102015743A (zh) * | 2008-02-08 | 2011-04-13 | 本尤明·A·科恩 | 钌化合物和组合物 |
CN103298804A (zh) * | 2009-04-29 | 2013-09-11 | 多异亚德韩国株式会社 | 新的二氢卟酚e6-叶酸共轭物、其制备方法以及含有该共轭物的用于癌症治疗的药物组合物 |
CN103239718A (zh) * | 2013-05-13 | 2013-08-14 | 江苏大学 | 负载阿霉素的聚己内酯-嵌段-聚乙二醇纳米微球的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN106674286A (zh) | 2017-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104402939A (zh) | 一种铱金属配合物及其制备方法和用途 | |
CN107400146A (zh) | 一种抗肿瘤金属铱(ⅲ)配合物及其制备方法和应用 | |
Baul et al. | New dibutyltin (iv) ladders: Syntheses, structures and, optimization and evaluation of cytotoxic potential employing a375 (melanoma) and hct116 (colon carcinoma) cell lines in vitro | |
Ahmad et al. | Organotin (IV) derivatives of amide-based carboxylates: Synthesis, spectroscopic characterization, single crystal studies and antimicrobial, antioxidant, cytotoxic, anti-leishmanial, hemolytic, noncancerous, anticancer activities | |
CN108358977A (zh) | 一种双核钌的Schiff碱配合物的制备方法及其应用 | |
Qi et al. | Synthesis, structure and anticancer studies of Cu (Ⅱ) and Ni (Ⅱ) complexes based on 2-hydroxy-1-naphthaldehyde-4-aminoantipyrine Schiff-base | |
CN106632494B (zh) | 卟啉芳基钌配合物及其制备方法和用途 | |
CN102964387B (zh) | 一种有机金属钌离子对化合物及其制备方法和用途 | |
CN106674286B (zh) | 四苯基卟啉乙醚芳基钌化合物及制备方法和用途 | |
CN106588995B (zh) | 酞菁-芳基钌化合物及其制备方法和用途 | |
CN106749422B (zh) | 四苯基卟啉芳基钌化合物及其制备方法和用途 | |
CN106632493B (zh) | 四苯基卟啉连二胺芳基钌化合物及其制备方法和用途 | |
Paul et al. | Unfolding biological properties of a versatile dicopper (II) precursor and its two mononuclear copper (II) derivatives | |
CN107827934B (zh) | 具有抗癌活性的四价铂配合物、制备方法及应用 | |
CN107488198B (zh) | 一种色胺酮铂配合物及其合成方法与应用 | |
CN106588994B (zh) | 酞菁芳基钌配合物及其制备方法和用途 | |
CN108690090A (zh) | 一种钌的Schiff碱配合物的制备方法及其抗肿瘤的应用 | |
CN102964385B (zh) | 一种有机金属钌化合物及其制备方法和用途 | |
CN106588939B (zh) | 酞菁-芳基钌化合物及其制备方法和用途 | |
CN106588996B (zh) | 酞菁芳基钌配合物及其制备方法和用途 | |
CN103288881B (zh) | 一种具有抗肿瘤活性的双核金属钌配合物 | |
CN110423242A (zh) | 6,7-二氯喹啉-5,8-二酮衍生物过渡金属配合物及其合成方法和应用 | |
CN105481944B (zh) | 一种苯并咪唑衍生物二肽铜配合物及其制备方法和应用 | |
CN109553590A (zh) | 具有谷胱甘肽巯基转移酶抑制功能的化合物及其制备方法 | |
CN108456231B (zh) | 一种双卤代香豆素-铂(ii)配合物及其合成方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: Mingxiu Road East of Nanning city the Guangxi Zhuang Autonomous Region 530001 Guangxi Teachers Education University No. 175 Patentee after: NANNING NORMAL University Address before: Mingxiu Road East of Nanning city the Guangxi Zhuang Autonomous Region 530001 Guangxi Teachers Education University No. 175 Patentee before: Guangxi Normal University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191113 Address after: 210000 No.1, Xiushan Middle Road, Lishui Economic Development Zone, Nanjing City, Jiangsu Province Patentee after: NANJING ADVANCED BIOMATERIALS AND PROCESS EQUIPMENT RESEARCH INSTITUTE Co.,Ltd. Address before: Mingxiu Road East of Nanning city the Guangxi Zhuang Autonomous Region 530001 Guangxi Teachers Education University No. 175 Patentee before: Nanning Normal University |